Literature DB >> 21690617

Incidence and severity of invasive Streptococcus pneumoniae, group A Streptococcus, and group B Streptococcus infections among pregnant and postpartum women.

Meredith Deutscher1, Melissa Lewis, Elizabeth R Zell, Thomas H Taylor, Chris Van Beneden, Stephanie Schrag.   

Abstract

BACKGROUND: The epidemiology of streptococcal infection in pregnant and postpartum women is poorly described in recent literature. We used data from multistate surveillance for invasive Streptococcus pneumoniae, group A Streptococcus (GAS), and group B Streptococcus (GBS) infections to estimate disease incidence and severity in these populations.
METHODS: Cases were reported through the Centers for Disease Control and Prevention Active Bacterial Core surveillance, an active population- and laboratory-based system. A case was defined as illness in a woman aged 15-44 years with streptococcus isolated from a normally sterile body site during 2007-2009. Pregnant or postpartum status was recorded at the time of culture. Incidence was calculated as cases per 1000 woman-years with use of national Census data; 95% confidence intervals were calculated on the basis of λ distribution. We used multivariable logistic regression to explore associations between pregnant or postpartum status and hospital length of stay, a marker of disease severity.
RESULTS: We identified 1848 cases in women; 6.0% of women were pregnant, and 7.5% were postpartum. Pregnant women had a higher mean incidence of GBS disease, compared with nonpregnant women (0.04 cases per 1000 woman-years [range, 0.03-0.05 cases per 1000 woman-years] vs 0.02 cases per 1000 woman-years [range, 0.02-0.02 cases per 1000 woman-years]). Postpartum women had elevated mean incidence of all 3 pathogens, compared with nonpregnant women (S. pneumoniae: 0.15 cases per 1000 woman-years [range, 0.09-0.25 cases per 1000 woman-years] vs 0.052 cases per 1000 woman-years [range, 0.049-0.056 cases per 1000 woman-years]; GAS: 0.56 cases per 1000 woman-years [range, 0.42-0.70 cases per 1000 woman-years] vs 0.019 cases per 1000 woman-years [range, 0.017-0.021 cases per 1000 woman-years]; GBS: 0.49 cases per 1000 woman-years [range, 0.36-0.64 cases per 1000 woman-years] vs 0.018 [range, 0.016-0.020 cases per 1000 woman-years]). Neither pregnancy nor postpartum status was associated with longer length of stay among women infected with any of the 3 pathogens.
CONCLUSIONS: Although invasive streptococcal infections do not appear to be more severe in pregnant or postpartum women, postpartum women have a 20-fold increased incidence of GAS and GBS, compared with nonpregnant women.

Entities:  

Mesh:

Year:  2011        PMID: 21690617     DOI: 10.1093/cid/cir325

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  41 in total

Review 1.  Role of pore-forming toxins in bacterial infectious diseases.

Authors:  Ferdinand C O Los; Tara M Randis; Raffi V Aroian; Adam J Ratner
Journal:  Microbiol Mol Biol Rev       Date:  2013-06       Impact factor: 11.056

2.  A Mobile Genetic Element Promotes the Association Between Serotype M28 Group A Streptococcus Isolates and Cases of Puerperal Sepsis.

Authors:  Ira Jain; Poulomee Sarkar; Jessica L Danger; Josette Medicielo; Roshika Roshika; Gregory Calfee; Anupama Ramalinga; Cameron Burgess; Paul Sumby
Journal:  J Infect Dis       Date:  2019-07-31       Impact factor: 5.226

3.  An unusual case of Streptococcus agalactiae meningitis in a patient with sys-temic lupus erythematosus.

Authors:  E Protonotariou; A Arampatzi; V Ourailoglou; E Diza; L Skoura
Journal:  Hippokratia       Date:  2015 Oct-Dec       Impact factor: 0.471

Review 4.  Population-based epidemiology and microbiology of community-onset bloodstream infections.

Authors:  Kevin B Laupland; Deirdre L Church
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

5.  EP4 and EP2 receptor activation of protein kinase A by prostaglandin E2 impairs macrophage phagocytosis of Clostridium sordellii.

Authors:  Lisa M Rogers; Tennille Thelen; Krystle Fordyce; Emilie Bourdonnay; Casey Lewis; Han Yu; Junyong Zhang; Jingli Xie; Carlos H Serezani; Marc Peters-Golden; David M Aronoff
Journal:  Am J Reprod Immunol       Date:  2013-08-01       Impact factor: 3.886

6.  Streptococcus pyogenes infects human endometrium by limiting the innate immune response.

Authors:  Antonin Weckel; Thomas Guilbert; Clara Lambert; Céline Plainvert; François Goffinet; Claire Poyart; Céline Méhats; Agnès Fouet
Journal:  J Clin Invest       Date:  2021-02-15       Impact factor: 14.808

7.  Leukotriene B4 enhances innate immune defense against the puerperal sepsis agent Streptococcus pyogenes.

Authors:  Elyara M Soares; Katie L Mason; Lisa M Rogers; Carlos H Serezani; Lucia H Faccioli; David M Aronoff
Journal:  J Immunol       Date:  2013-01-16       Impact factor: 5.422

8.  Evolving microbiological epidemiology and high fetal mortality in 135 cases of bacteremia during pregnancy and postpartum.

Authors:  L Surgers; N Valin; B Carbonne; E Bingen; V Lalande; J Pacanowski; M-C Meyohas; P-M Girard; J-L Meynard
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-08-21       Impact factor: 3.267

9.  Pathology Associated With Streptococcus spp. Infection in Baboons (Papio spp.).

Authors:  Katelin L Davis; Olga Gonzalez; Shyamesh Kumar; Edward J Dick
Journal:  Vet Pathol       Date:  2020-08-03       Impact factor: 2.221

10.  Intrauterine group A streptococcal infections are exacerbated by prostaglandin E2.

Authors:  Katie L Mason; Lisa M Rogers; Elyara M Soares; Tara Bani-Hashemi; John Erb Downward; Dalen Agnew; Marc Peters-Golden; Jason B Weinberg; Leslie J Crofford; David M Aronoff
Journal:  J Immunol       Date:  2013-08-02       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.